By Regulatory Approvals — FDA Approves Opus Genetics’ Phentolamine Ophthalmic Solution 0.75% to Treat Presbyopia VisionMonday.com
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 19, 2026.